R. Hector MacKay-Dunn, Director at Aurinia Pharmaceuticals, holds 18.59K shares in Aurinia Pharmaceuticals (Ticker: AUPH). Most recently, R. Hector MacKay-Dunn Sold $5,630 shares of Aurinia Pharmaceuticals on May 22, 2024 for an estimated value of 32.32K.